EHS
EHS

Tentarix Bio unveils $50M for biologics with multiple functions, multiple targets


Biotech startup Tentarix Biotherapeutics has come out of stealth with $50 million and technology that develops biologic drugs endowed with multiple functions. The company aims to develop new multispecific biologic drugs for cancer and autoimmune diseases.

Source link

EHS
Back to top button